Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications.
Simopoulos
Artemis P
AP
D016718:Arachidonic Acid / Q000502:physiology; D050197:Atherosclerosis / Q000517:prevention & control; D005075:Biological Evolution; D001921:Brain / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000517:prevention & control; D004032:Diet / Q000379:methods*; D004041:Dietary Fats; D015118:Eicosapentaenoic Acid / Q000502:physiology; D015525:Fatty Acids, Omega-3 / Q000502:physiology*; D043371:Fatty Acids, Omega-6 / Q000502:physiology*; D005231:Fatty Acids, Unsaturated / Q000502:physiology; D015870:Gene Expression / Q000502:physiology; D005786:Gene Expression Regulation / Q000502:physiology; D014644:Genetic Variation / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000517:prevention & control; D019787:Linoleic Acid / Q000502:physiology; D018673:Nutrition Policy; D009751:Nutritional Requirements; D044242:Trans Fatty Acids / Q000502:physiology
D004041:Dietary Fats; D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; D044242:Trans Fatty Acids; D016718:Arachidonic Acid; D019787:Linoleic Acid; D015118:Eicosapentaenoic Acid; C026219:docosapentaenoic acid